Three abstracts were presented from Photocure's U.S. Blue Light Cystoscopy with Cysview Registry, a large multicenter bladder cancer patient registry of real-world data, established by Photocure ...

The cystoscopy looks for any cause of tissue ... Long-term side effects of BCG treatment for bladder cancer Long-term side effects of BCG treatment are rare, but they may include urinary tract ...

AUA annual meeting featured the 4 th annual IBCG Bladder Cancer Forum evaluating common problems and controversies in bladder ...

WHICH CAN SAVE YOU FROM A CYSTOSCOPY IF IT SHOWS THAT YOUR RISK OF BLADDER CANCER IS VERY LOW OR VERY HIGH, AND IT PUSHES YOU MORE TOWARDS MORE SCREENING AND MORE SCOPES IN TERMS OF TREATMENT ...

Among patients with non-muscle-invasive bladder cancer (NMIBC), neoadjuvant treatment with mitomycin C prior to transurethral ...

Photodynamic therapy using TLD-1433 represents a viable treatment option for BCG-unresponsive NMIBC CIS with an acceptable safety profile. Light-activated TLD-1433 photodynamic therapy (PDT) may ...

Photocure ASA (OSE: PHO) today reported Hexvix®/Cysview® revenues of NOK 125.3 million in the first quarter of 2025 (Q1 2024: NOK ...

Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical ...

Three abstracts were presented from Photocure's U.S. Blue Light Cystoscopy with Cysview Registry, a large multicenter bladder cancer patient registry of real-world data, established by Photocure in ...

OSLO, Norway, April 29, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces four abstract presentations at the AUA 2025, highlighting the benefits of Blue Light ...